Raising awareness for World Neuroendocrine Cancer Day Understanding EP-NEC: Through diagnosis, treatment, and support What do the differences between NETs and NECs mean for patients? >> Poorly differentiated, high-grade, aggressive cancers need urgent treatment options. Find

📢 Raising awareness for #WorldNeuroendocrineCancerDay Understanding EP-NEC: Through diagnosis, treatment, and support What do the differences between NETs and NECs mean for patients? >> Poorly differentiated, high-grade, aggressive cancers need urgent treatment options. Find

EP-NECs are rare, aggressive, high-grade neuroendocrine cancers and are very different from most NETs. But how can HCPs distinguish NECs from NETs, and what does this mean for patients? 🎧 Stay tuned for our upcoming podcast with @AmanChauhanMD and Susan Meckler-Plummer from

🎉 @COR2EDMedEd now has over 20,000 YouTube subscribers! 🎉 NET CONNECT is an initiative of COR2ED - come and find us on YouTube! Join over 20k healthcare professionals who follow us on YouTube to stay up to date with high-quality, engaging medical education programmes from

Dr @helops79, @ProfKHerrmann & @OncBrothers share their perspectives on advances in the management of #neuroendocrine tumours Spotlight on the role of radioligand therapy and its impact on clinical practice 🔦 📹 Video in this post 🤝 Endorsed by @NANETS1, CommNETs

Expert perspectives on PRRT and emerging strategies in #neuroendocrine tumours Explore diagnostic strategies, pt selection based on clinical trials, safety profiles/AE mgmt, future directions & more! Here's a short video teaser... see the full video & find out more >>

NETs: Understanding key clinical studies, like COMPETE and NETTER-1 and -2 helps you pair the right patient with the right treatment ✅ What else do you need to know about radiopharmaceutical treatment for #NETs? Experts discuss management strategies, future directions, and

📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer, and showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME

How can new clinical trials in radioligand therapy impact clinical practice in NET treatment strategies? 📹 Find out in this new #MedEd video from Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1, CommNETs (@GICancer) & @ncukcharity Supported by an Independent

Now available! Explore the evolving role of PRRT in NETs Tap to enlarge the infographic📜 Optimising treatment strategies needs an understanding of the clinical trial data and how studies differ View the infographic to differentiate between key clinical studies, including

In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism

New podcast! Expert perspectives on PRRT and emerging strategies in NETs 📹 Explore diagnostic strategies, pt selection based on clinical trials, safety profiles/AE mgmt, future directions & more! w/ Dr @helops79 @ProfKHerrmann @OncBrothers Endorsed by @NANETS1, CommNETs

📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer & showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME #MedTwitter

🎉COR2ED has over 12k subscribers on YouTube! 🎉 Do you follow us? ▶️ https://t.co/LnFf4HZKkj Join over 12k HCPs on our YouTube channel and stay up to date with #MedEd videos as they’re released 🎓 #MedicalEducation #Oncology #NET

Huge congratulations to the newly elected @myESMO Directors and Nomination Committee members! A special mention to: 👏 @giconnectInfo member, Dr @LizzySmyth1, who has been elected as the new Director of Education 👏 @PresOnc_Connect member, Prof. @ulassen, who was elected as

Did you catch our recent podcast series? In Ep.1, Dr Mohid Khan & patient advocate Sally Jenkins discuss shared decision-making, and in Ep. 2 they explore how to individualise treatment decisions for better patient outcomes. #LetsTalkAboutNETs Take a look at the highlights📹

📺 Explore our free #MedED resource developed by Prof. Emily Bergsland and Prof. Louis de Mestier. With practical tools for optimising advanced #NETs treatment and management, focusing on key tumour, patient, and treatment factors. Discover it today! https://t.co/H4ve7OeWop

🔔FREE NEN education for GPs: All you need to know to detect neuroendocrine cancer in general practice only in 60 minutes. CME-accredited, in 6 languages. 🎯Enroll now to #ThinkNENs: https://t.co/wFNB7DhjwL #LetsTalkAboutNETs #MedTwitter #EndoTwitter #generalpractitioners #MedEd

The @COR2EDMedEd YouTube account has surpassed 3k subscribers! 🎉 Go and check it out 👇 #MedEd

🎙️ Have you listened to our latest podcast yet? We dive into the important topics of shared decision-making and personalised care. Join experts as they discuss how to improve communication and tailor #NET treatment to fit individual needs. https://t.co/RO5J0GVX6l #MedEd